Reimbursement and use of oral anticoagulants during 2014–2022 - A register-based study

BACKGROUND: Vitamin K antagonists, warfarin in particular, have been the mainstay of anticoagulation therapy, but their use has declined in many countries since direct oral anticoagulants (DOACs) have entered the market. OBJECTIVE: To examine utilization trends of oral anticoagulants (OACs) in Finla...

Descripción completa

Detalles Bibliográficos
Autores principales: Aarnio, Emma, Huupponen, Risto, Martikainen, Janne, Korhonen, Maarit J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393798/
https://www.ncbi.nlm.nih.gov/pubmed/37538990
http://dx.doi.org/10.1016/j.rcsop.2023.100284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393798/
https://www.ncbi.nlm.nih.gov/pubmed/37538990
http://dx.doi.org/10.1016/j.rcsop.2023.100284

Ejemplares similares